Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024855 · ClinicalTrials.gov registry record · Phase 1
Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
A Phase 1 study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01024855 is a Phase 1 study that has completed, run by Abbott Medical Optics. The registered enrollment target is 30 participants.
The verdict
NCT01024855, a Phase 1 study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
A new multi-purpose solution (MPS)was clinically evaluated against Opti-Free RepleniSH MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
Interventions
- DEVICE RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01024855
The ClinicalTrials.gov registry entry for NCT01024855 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control) is the first listed.
NCT01024855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01024855 about?
NCT01024855 is a clinical study titled "Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions". A new multi-purpose solution (MPS)was clinically evaluated against Opti-Free RepleniSH MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.
What is the current status of trial NCT01024855?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01024855?
The interventions under investigation include: RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control) (DEVICE).
Who is sponsoring clinical trial NCT01024855?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.